Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
IRX4204
i
Other names:
IRX4204, NRX194204, AGN-194204, ALRT-4204, NRX-4204, VTP-194204, IRX-4204, IRX 4204, NRX4204, NRX 4204, NRX 194204, NRX-194204, AGN194204, AGN 194204, VTP 194204, VTP194204, rexinoid
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(4)
News
Trials
Company:
Io Therap
Drug class:
Retinoid X receptor agonist
Related drugs:
‹
MSU-42011 (0)
alitretinoin topical (0)
bexarotene topical (0)
UAB30 (0)
K-333 (0)
MSU-42011 (0)
alitretinoin topical (0)
bexarotene topical (0)
UAB30 (0)
K-333 (0)
›
Associations
(4)
News
Trials
VERI cancer hierarchy
Reset Filters
HER-2 overexpression
Breast Cancer
HER-2 overexpression
Breast Cancer
neratinib + IRX4204
Sensitive: D – Preclinical
neratinib + IRX4204
Sensitive
:
D
neratinib + IRX4204
Sensitive: D – Preclinical
neratinib + IRX4204
Sensitive
:
D
HER-2 overexpression
Breast Cancer
HER-2 overexpression
Breast Cancer
tucatinib + IRX4204
Sensitive: D – Preclinical
tucatinib + IRX4204
Sensitive
:
D
tucatinib + IRX4204
Sensitive: D – Preclinical
tucatinib + IRX4204
Sensitive
:
D
HER-2 overexpression
Breast Cancer
HER-2 overexpression
Breast Cancer
trastuzumab + IRX4204
Sensitive: D – Preclinical
trastuzumab + IRX4204
Sensitive
:
D
trastuzumab + IRX4204
Sensitive: D – Preclinical
trastuzumab + IRX4204
Sensitive
:
D
HER-2 overexpression
Breast Cancer
HER-2 overexpression
Breast Cancer
IRX4204
Sensitive: D – Preclinical
IRX4204
Sensitive
:
D
IRX4204
Sensitive: D – Preclinical
IRX4204
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.